[1] Thayre WS. Evaluation of tissue indications of oxidative stress in rats treated chronically with adriamycin [J]. Biochem Pharmacol, 1988,37: 2189-94. [2] 李晖,李钰,宋其林,等.阿霉素致大鼠线粒体DNA突变及硒的保护作用[J].中国地方病学杂志,1998,17(1):12-5.Li H, Li Y, Song QL, et al. Mitochondrial DNA injuries induced by adriamycin and selenium protective action in rat cardiomyocytes[J]. Chin J Endemicl Dis, 1998,17(1): 12-5. [3] Michael R, Dangshe Ma, Lawrenrence TL, et al. Tumor therapy with targeted atomic nanogenerator [J]. Science, 2001 (294): 1537-42. [4] Andreas SL, Chrcistain B, Winfried H, et al. Preclinical experiences with magnetic drug targeting: Tolerance and efficacy [J]. Cancer Res, 1996(56): 4964-9. [5] Hanansson L, hakansson A, Morales, et al. Spherex(degradable starch microspheres) chemo-occlusion-enhancement of rumor drug concentration and therapeutic efficacy: an overview [J]. Semin Oncol, 1997(24): s6-100. [6] 韩国宏,郭庆林,郭宇良,等.阿霉素不同剂型经肝动脉给药治疗肝癌的体内药动学研究[J].癌症,1998,17(3):194-6Han GH, Guo QL, Guo YL, et al. A study of the pharmacokinetics and biodistribution of doxorubicin in different formulation injected to hepatic artery for hepatocellular carcinoma [J]. Chin J Cancer, 1998,17(3): 194-6. [7] 程红岩,徐爱民,陈栋,等.肝癌介入治疗的相关因素与死亡时间关系探讨[J].中华肿瘤杂志,2001,23(6):497-500.Chen HY, Xu AM, Chen D, et al. Relation between transcatheter arterial chemoembolization and time of death in patients with hepatic carcinoma[J].Chin J Oncol, 2001, 23(6): 497-500. |